Startup backed by big names aims to detect early cancer in blood
STAT The startup, called Grail, aims to fish little bits of genetic material out of the blood, sequence them, and use them to identify extremely early cancers. It’s being spun out of Illumina, Inc., a global giant in gene sequencing and backed by $100 … A Single Blood Test For All Cancers? Illumina, Bill Gates and Jeff Bezos …Forbes Illumina’s Bid to Beat Cancer with DNA TestsMIT Technology Review all 26 news articles |
From:: Startup Tech News From Google News